Inventors:
Olga Bandman - Mountain View CA, US
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Mark Borowsky - Needham MA, US
Brendan Duggan - Sunnyvale CA, US
Brooke Emerling - Chicago IL, US
Ian Forsythe - Edmonton CA, US
Ameena Ganhi - San Francisco CA, US
Jennifer Griffin - Fremont CA, US
Rajagopal Gururajan - San Jose CA, US
April Hafalia - Daly City CA, US
Farrah Khan - Canton MI, US
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Kensington CA, US
Soo Lee - Mountain View CA, US
Erika Lindquist - Alameda CA, US
Dyung Aina Lu - San Jose CA, US
Yan Lu - Mountain View CA, US
Joseph Marquis - San Jose CA, US
Danniel Nguyen - San Jose CA, US
Chandra Arvizu - San Diego CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Shirley Recipon - San Francisco CA, US
Thomas Richardson - Redwood City CA, US
Anita Swarnakar - San Francisco CA, US
Michael Thornton - Oakland CA, US
Uyen Tran - San Jose CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - San Marcos CA, US
Junming Yang - San Jose CA, US
Monique Yao - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Yeganeh Zebarjadian - San Francisco CA, US
International Classification:
C12Q001/68, C07H021/04, C12N009/12, C12N009/16
US Classification:
435006000, 435069100, 435194000, 435196000, 435320100, 435325000, 536023200
Abstract:
Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.